Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer risk.

Barry KH, Koutros S, Andreotti G, Sandler DP, Burdette LA, Yeager M, Beane Freeman LE, Lubin JH, Ma X, Zheng T, Alavanja MC, Berndt SI.

Carcinogenesis. 2012 Feb;33(2):331-7. doi: 10.1093/carcin/bgr258.

2.

Genetic variation in base excision repair pathway genes, pesticide exposure, and prostate cancer risk.

Barry KH, Koutros S, Berndt SI, Andreotti G, Hoppin JA, Sandler DP, Burdette LA, Yeager M, Freeman LE, Lubin JH, Ma X, Zheng T, Alavanja MC.

Environ Health Perspect. 2011 Dec;119(12):1726-32. doi: 10.1289/ehp.1103454.

3.

Pesticide exposure and inherited variants in vitamin d pathway genes in relation to prostate cancer.

Karami S, Andreotti G, Koutros S, Barry KH, Moore LE, Han S, Hoppin JA, Sandler DP, Lubin JH, Burdette LA, Yuenger J, Yeager M, Freeman LE, Blair A, Alavanja MC.

Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1557-66. doi: 10.1158/1055-9965.EPI-12-1454.

4.

Pesticide use modifies the association between genetic variants on chromosome 8q24 and prostate cancer.

Koutros S, Beane Freeman LE, Berndt SI, Andreotti G, Lubin JH, Sandler DP, Hoppin JA, Yu K, Li Q, Burdette LA, Yuenger J, Yeager M, Alavanja MC.

Cancer Res. 2010 Nov 15;70(22):9224-33. doi: 10.1158/0008-5472.CAN-10-1078.

5.

Genetic susceptibility loci, pesticide exposure and prostate cancer risk.

Koutros S, Berndt SI, Hughes Barry K, Andreotti G, Hoppin JA, Sandler DP, Yeager M, Burdett LA, Yuenger J, Alavanja MC, Beane Freeman LE.

PLoS One. 2013 Apr 4;8(4):e58195. doi: 10.1371/journal.pone.0058195.

6.

The Interaction between Pesticide Use and Genetic Variants Involved in Lipid Metabolism on Prostate Cancer Risk.

Andreotti G, Koutros S, Berndt SI, Hughes Barry K, Hou L, Hoppin JA, Sandler DP, Lubin JH, Burdette LA, Yuenger J, Yeager M, Beane Freeman LE, Alavanja MC.

J Cancer Epidemiol. 2012;2012:358076. doi: 10.1155/2012/358076.

7.

Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer.

Koutros S, Andreotti G, Berndt SI, Hughes Barry K, Lubin JH, Hoppin JA, Kamel F, Sandler DP, Burdette LA, Yuenger J, Yeager M, Alavanja MC, Freeman LE.

Pharmacogenet Genomics. 2011 Oct;21(10):615-23. doi: 10.1097/FPC.0b013e3283493a57.

8.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33.

PMID:
17925536
9.

Sex Steroid Hormone Single-Nucleotide Polymorphisms, Pesticide Use, and the Risk of Prostate Cancer: A Nested Case-Control Study within the Agricultural Health Study.

Christensen CH, Barry KH, Andreotti G, Alavanja MC, Cook MB, Kelly SP, Burdett LA, Yeager M, Beane Freeman LE, Berndt SI, Koutros S.

Front Oncol. 2016 Nov 21;6:237.

10.

Fonofos exposure and cancer incidence in the agricultural health study.

Mahajan R, Blair A, Lynch CF, Schroeder P, Hoppin JA, Sandler DP, Alavanja MC.

Environ Health Perspect. 2006 Dec;114(12):1838-42.

11.

NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans.

Hooker S, Bonilla C, Akereyeni F, Ahaghotu C, Kittles RA.

Prostate Cancer Prostatic Dis. 2008;11(4):349-56.

PMID:
18026184
12.

Tagging single nucleotide polymorphisms in excision repair cross-complementing group 1 (ERCC1) and risk of primary lung cancer in a Chinese population.

Ma H, Xu L, Yuan J, Shao M, Hu Z, Wang F, Wang Y, Yuan W, Qian J, Wang Y, Xun P, Liu H, Chen W, Yang L, Jin G, Huo X, Chen F, Shugart YY, Jin L, Wei Q, Wu T, Shen H, Huang W, Lu D.

Pharmacogenet Genomics. 2007 Jun;17(6):417-23.

PMID:
17502833
13.

Replication of prostate cancer risk loci in a Japanese case-control association study.

Yamada H, Penney KL, Takahashi H, Katoh T, Yamano Y, Yamakado M, Kimura T, Kuruma H, Kamata Y, Egawa S, Freedman ML.

J Natl Cancer Inst. 2009 Oct 7;101(19):1330-6. doi: 10.1093/jnci/djp287.

PMID:
19726753
14.

Genetic variation in the nucleotide excision repair pathway and bladder cancer risk.

García-Closas M, Malats N, Real FX, Welch R, Kogevinas M, Chatterjee N, Pfeiffer R, Silverman D, Dosemeci M, Tardón A, Serra C, Carrato A, García-Closas R, Castaño-Vinyals G, Chanock S, Yeager M, Rothman N.

Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):536-42.

15.

Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.

Xing J, Dinney CP, Shete S, Huang M, Hildebrandt MA, Chen Z, Gu J.

Cancer. 2012 Jan 1;118(1):205-15. doi: 10.1002/cncr.26224.

16.

Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study.

Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL.

Cancer Causes Control. 2010 Feb;21(2):289-300. doi: 10.1007/s10552-009-9461-5.

17.

Polymorphisms of DNA repair-related genes with susceptibility and prognosis of prostate cancer.

Zhang XJ, Liu P, Zhu F.

Genet Mol Res. 2014 Jan 24;13(2):4419-24. doi: 10.4238/2014.January.24.20.

18.

Influence of a single-nucleotide polymorphism of the DNA mismatch repair-related gene exonuclease-1 (rs9350) with prostate cancer risk among Chinese people.

Zhang Y, Li P, Xu A, Chen J, Ma C, Sakai A, Xie L, Wang L, Na Y, Kaku H, Xu P, Jin Z, Li X, Guo K, Shen H, Zheng S, Kumon H, Liu C, Huang P.

Tumour Biol. 2016 May;37(5):6653-9. doi: 10.1007/s13277-015-4298-x.

PMID:
26646562
19.

Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.

Sun J, Wiklund F, Zheng SL, Chang B, Bälter K, Li L, Johansson JE, Li G, Adami HO, Liu W, Tolin A, Turner AR, Meyers DA, Isaacs WB, Xu J, Grönberg H.

J Natl Cancer Inst. 2005 Apr 6;97(7):525-32.

PMID:
15812078
20.

DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.

Mandal RK, Gangwar R, Mandhani A, Mittal RD.

DNA Cell Biol. 2010 Apr;29(4):183-90. doi: 10.1089/dna.2009.0956.

PMID:
20070155

Supplemental Content

Support Center